000
| 01090nam##2200265za#4500 |
---|
001 | 9.688015 |
---|
003 | CaOODSP |
---|
005 | 20210624231232 |
---|
007 | cr ||||||||||| |
---|
008 | 150407|2005||||xxc|||||o f|0| 0 eng|d |
---|
020 | |a0-662-42457-3 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH169-2/2005E-PDF |
---|
110 | 1 |aCanada.|bHealth Canada. |bTherapeutic Products Directorate. |
---|
245 | 10|aGuidance for industry : |h[electronic resource]|bmanagement of drug submissions |
---|
260 | |aOttawa - Ontario : |bHealth Canada. |c2005. |
---|
300 | |a41p.|bglossary, table |
---|
500 | |aThe catalogue number (H169-2/2005E) and ISBN (0-662-42456-5) for the print edition have been incorrectly copied in this electronic publication. |
---|
590 | |a07-07|b2007-02-16 |
---|
690 | 07|aApproval processes|2gcpds |
---|
690 | 07|aDrugs|2gcpds |
---|
775 | 08|tLigne directrice à l'intention de l'industrie : |w(CaOODSP)9.632456 |
---|
794 | |tGuidance document : |w(CaOODSP)9.873424 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s636 KB|uhttps://publications.gc.ca/collections/Collection/H169-2-2005E.pdf |
---|